Compounds > combretastatin
Page last updated: 2024-08-26

combretastatin and Liver Neoplasms

combretastatin has been researched along with Liver Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, X; Liu, F; Tang, J; Yuan, H; Zhou, M1
Cao, L; Zhang, L; Zhang, Y; Zhao, X1

Other Studies

2 other study(ies) available for combretastatin and Liver Neoplasms

ArticleYear
Local application of doxorubicin- loaded Iron oxid nanoparticles and the vascular disrupting agent via the hepatic artery: chemoembolization-photothermal ablation treatment of hepatocellular carcinoma in rats.
    Cancer imaging : the official publication of the International Cancer Imaging Society, 2019, Nov-04, Volume: 19, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Bibenzyls; Carcinoma, Hepatocellular; Cell Proliferation; Chemoembolization, Therapeutic; Doxorubicin; Ferric Compounds; Indoles; Laser Therapy; Liver Neoplasms; Magnetic Resonance Imaging; Metal Nanoparticles; Polymers; Rats; Rats, Sprague-Dawley

2019
A Hybrid Chalcone Combining the Trimethoxyphenyl and Isatinyl Groups Targets Multiple Oncogenic Proteins and Pathways in Hepatocellular Carcinoma Cells.
    PloS one, 2016, Volume: 11, Issue:8

    Topics: Antineoplastic Agents; Apoptosis; Bibenzyls; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Chalcone; Cytoskeleton; Focal Adhesions; Hep G2 Cells; Humans; Isatin; Liver Neoplasms; Molecular Targeted Therapy; Oncogene Proteins; Paxillin; Protein Multimerization; Protein Structure, Quaternary; Tubulin; Vacuoles; Wnt Signaling Pathway

2016